Trademark: 88573422
Word
NINEMETERS BIOPHARMA
Status
Dead
Status Code
606
Status Date
Monday, March 27, 2023
Serial Number
88573422
Mark Type
4000
Filing Date
Friday, August 9, 2019
Published for Opposition
Tuesday, December 24, 2019
Abandoned Date
Monday, March 27, 2023

Trademark Owner History
9 METERS BIOPHARMA - 1st New Owner After Publication
RDD Pharma, Inc. - Owner At Publication

Classifications
5 Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form namely, gels, ointments and pastes, suppositories, in liquid form namely, drops, injectables, infusions, in gaseous form namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories
42 Pharmaceutical research and development services; Medical and scientific research information in the field of novel pharmaceutical discovery and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of novel pharmaceutical treatments and clinical trials; Providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; Clinical trials services for others
NINE METERS BIO PHARMA
"BIOPHARMA"

Trademark Events
Mar 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 27, 2023
Abandonment - No Use Statement Filed
Aug 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2022
Sou Extension 5 Granted
Aug 4, 2022
Sou Extension 5 Filed
Aug 12, 2022
Case Assigned To Intent To Use Paralegal
Aug 4, 2022
Teas Extension Received
Feb 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 11, 2022
Sou Extension 4 Granted
Feb 11, 2022
Sou Extension 4 Filed
Feb 11, 2022
Teas Extension Received
Dec 22, 2021
Automatic Update Of Assignment Of Ownership
Aug 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 18, 2021
Sou Extension 3 Granted
Aug 18, 2021
Sou Extension 3 Filed
Aug 18, 2021
Teas Extension Received
Dec 12, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 10, 2020
Sou Extension 2 Granted
Dec 10, 2020
Sou Extension 2 Filed
Dec 10, 2020
Teas Extension Received
Aug 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2020
Sou Extension 1 Granted
Aug 13, 2020
Sou Extension 1 Filed
Aug 13, 2020
Teas Extension Received
Feb 18, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 24, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 24, 2019
Published For Opposition
Dec 4, 2019
Notification Of Notice Of Publication E-Mailed
Nov 18, 2019
Assigned To Lie
Nov 14, 2019
Approved For Pub - Principal Register
Nov 14, 2019
Examiner's Amendment Entered
Nov 14, 2019
Notification Of Examiners Amendment E-Mailed
Nov 14, 2019
Examiners Amendment E-Mailed
Nov 14, 2019
Examiners Amendment -Written
Nov 14, 2019
Notification Of Non-Final Action E-Mailed
Nov 14, 2019
Non-Final Action E-Mailed
Nov 14, 2019
Non-Final Action Written
Nov 7, 2019
Assigned To Examiner
Aug 26, 2019
New Application Office Supplied Data Entered
Aug 13, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24